Table of Contents Author Guidelines Submit a Manuscript
Advances in Medicine
Volume 2016, Article ID 3917916, 9 pages
http://dx.doi.org/10.1155/2016/3917916
Research Article

CYP4F2 (rs2108622) Gene Polymorphism Association with Age-Related Macular Degeneration

1Lithuanian University of Health Sciences, Medical Academy, Eiveniu 2, LT-50009 Kaunas, Lithuania
2Neuroscience Institute, Lithuanian University of Health Sciences, Medical Academy, Eiveniu 2, LT-50009 Kaunas, Lithuania
3Department of Ophthalmology, Lithuanian University of Health Sciences, Medical Academy, Eiveniu 2, LT-50009 Kaunas, Lithuania

Received 13 April 2016; Revised 23 July 2016; Accepted 26 July 2016

Academic Editor: Xinhua Shu

Copyright © 2016 Ruta Sakiene et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. S. Lim, P. Mitchell, J. M. Seddon, F. G. Holz, and T. Y. Wong, “Age-related macular degeneration,” The Lancet, vol. 379, no. 9827, pp. 1728–1738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. R. D. Jager, W. F. Mieler, and J. W. Miller, “Age-related macular degeneration,” The New England Journal of Medicine, vol. 358, no. 24, pp. 2544–2617, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. Y.-F. Wang, Y. Han, R. Zhang, L. Qin, M.-X. Wang, and L. Ma, “CETP/LPL/LIPC gene polymorphisms and susceptibility to age-related macular degeneration,” Scientific Reports, vol. 5, Article ID 15711, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. R. W. Young, “Pathophysiology of age-related macular degeneration,” Survey of Ophthalmology, vol. 31, no. 5, pp. 291–306, 1987. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Zarbin, “Current concepts in the pathogenesis of age-related macular degeneration,” Archives of Ophthalmology, vol. 122, no. 4, pp. 598–614, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Loebstein, H. Yonath, D. Peleg et al., “Pharmacoepidemiology and drug utilization: interindividual variability in sensitivity to warfarin—nature or nurture?” Clinical Pharmacology and Therapeutics, vol. 70, no. 2, pp. 159–164, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Taube, D. Halsall, and T. Baglin, “Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment,” Blood, vol. 96, no. 5, pp. 1816–1819, 2000. View at Google Scholar · View at Scopus
  8. G. D'Andrea, R. L. D'Ambrosio, P. Di Perna et al., “A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin,” Blood, vol. 105, no. 2, pp. 645–649, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. D. Caldwell, T. Awad, J. A. Johnson et al., “CYK4F-2 genetic variant alters required warfarin dose,” Blood, vol. 111, no. 8, pp. 4106–4112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Koskela, M. Reinisalo, J. M. T. Hyttinen, K. Kaarniranta, and R. O. Karjalainen, “Pinosylvin-mediated protection against oxidative stress in human retinal pigment epithelial cells,” Molecular Vision, vol. 20, pp. 760–769, 2014. View at Google Scholar · View at Scopus
  11. G. Lai, J. Wu, X. Liu, and Y. Zhao, “20-HETE induces hyperglycemia through the cAMP/ PKA-PhK-GP pathway,” Molecular Endocrinology, vol. 26, no. 11, pp. 1907–1916, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. K. N. Theken, Y. Deng, M. Alison Kannon, T. M. Miller, S. M. Poloyac, and C. R. Lee, “Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism,” Drug Metabolism and Disposition, vol. 39, no. 1, pp. 22–29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. P. Hardwick, “Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases,” Biochemical Pharmacology, vol. 75, no. 12, pp. 2263–2275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Fava, M. Montagnana, E. Danese et al., “The functional variant V433M of the CYP4F2 and the metabolic syndrome in Swedes,” Prostaglandins and Other Lipid Mediators, vol. 98, no. 1-2, pp. 31–36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. Age-Related Eye Disease Study Research Group, “The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the age-related eye disease study report number,” American Journal of Ophthalmology, vol. 132, no. 5, pp. 668–681, 2001. View at Google Scholar
  16. K. L. Spencer, L. M. Olson, N. Schnetz-Boutaud et al., “Using genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degeneration,” PLoS ONE, vol. 6, no. 3, Article ID e17784, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. M. Cezario, M. C. Calastri, C. I. Oliveira et al., “Association of high-density lipoprotein and apolipoprotein E genetic variants with age-related maculardegeneration,” Arquivos Brasileiros de Oftalmologia, vol. 78, no. 2, pp. 85–88, 2015. View at Publisher · View at Google Scholar
  18. C. A. Curcio, M. Johnson, M. Rudolf, and J.-D. Huang, “The oil spill in ageing Bruch membrane,” British Journal of Ophthalmology, vol. 95, no. 12, pp. 1638–1645, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Björkhem, A. Cedazo-Minguez, V. Leoni, and S. Meaney, “Oxysterols and neurodegenerative diseases,” Molecular Aspects of Medicine, vol. 30, no. 3, pp. 171–179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Björkhem, O. Andersson, U. Diczfalusy et al., “Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 18, pp. 8592–8596, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. P. V. Luoma, “Cytochrome P450 and gene activation—from pharmacology to cholesterol elimination and regression of atherosclerosis,” European Journal of Clinical Pharmacology, vol. 64, no. 9, pp. 841–850, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Fourgeux, B. Dugas, F. Richard et al., “Single nucleotide polymorphism in the cholesterol-24SHydroxylase (CYP46A1) hene and Its association with CFH and LOC387715 gene polymorphisms in age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 53, no. 11, pp. 7026–7033, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. A. L. Hollman, P. B. Tchounwou, and H. C. Huang, “The Association between gene-environment interactions and diseases involving the human GST superfamily with SNP variants,” International Journal of Environmental Research and Public Health, vol. 13, no. 4, p. 379, 2016. View at Publisher · View at Google Scholar
  24. S. Yang, Y. He, J. Wang et al., “Genetic scores of smoking behaviour in a Chinese population,” Scientific Reports, vol. 6, Article ID 22799, 2016. View at Publisher · View at Google Scholar
  25. A. Munshi, V. Sharma, S. Kaul et al., “Association of 1347 G/A cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke,” Molecular Biology Reports, vol. 39, no. 2, pp. 1677–1682, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Cougnard-Grégoire, M.-N. Delyfer, J.-F. Korobelnik et al., “Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor study,” PLoS ONE, vol. 9, no. 3, Article ID e90973, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. U. Chakravarthy, T. Y. Wong, A. Fletcher et al., “Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis,” BMC Ophthalmology, vol. 10, article 31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Ulas, M. Balbaba, S. Ozmen, S. Celebi, and U. Dogan, “Association of dehydroepiandrosterone sulfate, serum lipids, C-reactive protein and body mass index with age-related macular degeneration,” International Ophthalmology, vol. 33, no. 5, pp. 485–491, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Cackett, T. Y. Wong, T. Aung et al., “Smoking, cardiovascular risk factors, and age-related macular degeneration in asians: the singapore malay eye study,” American Journal of Ophthalmology, vol. 146, no. 6, pp. 960–967.e1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Smith, P. Mitchell, S. R. Leeder, and J. J. Wang, “Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study,” Archives of Ophthalmology, vol. 116, no. 5, pp. 583–587, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. S. C. Tomany, J. J. Wang, R. Van Leeuwen et al., “Risk factors for incident age-related macular degeneration: pooled findings from 3 continents,” Ophthalmology, vol. 111, no. 7, pp. 1280–1287, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. K. B. Ebrahimi and J. T. Handa, “Lipids, lipoproteins, and age-related macular degeneration,” Journal of Lipids, vol. 2011, Article ID 802059, 14 pages, 2011. View at Publisher · View at Google Scholar
  33. B. M. Neale, J. Fagerness, R. Reynolds et al., “Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC),” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 16, pp. 7395–7400, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Cipriani, H.-T. Leung, V. Plagnol et al., “Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3,” Human Molecular Genetics, vol. 21, no. 18, pp. 4138–4150, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Chen, D. Stambolian, A. O. Edwards et al., “Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 16, pp. 7401–7406, 2010. View at Google Scholar
  36. N. A. Restrepo, K. L. Spencer, R. Goodloe et al., “Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study,” Investigative Ophthalmology & Visual Science, vol. 55, no. 10, pp. 6839–6850, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Reynolds, B. Rosner, and J. M. Seddon, “Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration,” Ophthalmology, vol. 117, no. 10, pp. 1989–1995, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Klein, C. E. Myers, G. H. S. Buitendijk et al., “Lipids, lipid genes, and incident age-related macular degeneration: the three continent age-related macular degeneration consortium,” American Journal of Ophthalmology, vol. 158, no. 3, pp. 513–524.e3, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. J. L. Haines, M. A. Hauser, S. Schmidt et al., “Complement factor H variant increases the risk of age-related macular degeneration,” Science, vol. 308, no. 5720, pp. 419–421, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. O. Zuk, E. Hechter, S. R. Sunyaev, and E. S. Lander, “The mystery of missing heritability: genetic interactions create phantom heritability,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 4, pp. 1193–1198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Ivashchenko, I. Rusin, D. Sychev, and A. Grachev, “The frequency of CYP2C9, VKORC1, and CYP4F2 polymorphisms in Russian patients with high thrombotic risk,” Medicina, vol. 49, no. 12, pp. 517–521, 2013. View at Google Scholar · View at Scopus
  42. H.-J. Cen, W.-T. Zeng, X.-Y. Leng et al., “CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement,” British Journal of Clinical Pharmacology, vol. 70, no. 2, pp. 234–240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Teichert, M. Eijgelsheim, F. Rivadeneira et al., “A genome-wide association study of acenocoumarol maintenance dosage,” Human Molecular Genetics, vol. 18, no. 19, pp. 3758–3768, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. W. T. Zeng, Q. S. Zheng, M. Huang et al., “Genetic polymorphisms of VKORC1, CYP2C9, CYP4F2 in Bai, Tibetan Chinese,” Pharmazie, vol. 67, no. 1, pp. 69–73, 2012. View at Google Scholar